
Always supportive and understanding.
Inspires students to love their studies.
Creates a collaborative and inclusive space.
Helps students build confidence and skills.
Great Professor!
Professor Robert Taylor is Professor of Mitochondrial Pathology in the Faculty of Medical Sciences at Newcastle University. He earned a BSc (Hons) in Biochemistry, a PhD, and a DSc from the University of Newcastle upon Tyne. Taylor is a Fellow of the Royal College of Pathologists (FRCPath) and a Fellow of the Academy of Medical Sciences (FMedSci). He heads the Newcastle NHS Highly Specialised Mitochondrial Diagnostic Laboratory, serves as Consultant Clinical Scientist at Newcastle upon Tyne Hospitals NHS Foundation Trust, and acts as Scientific Director of the North East and Yorkshire Genomic Laboratory Hub. As a research group leader in the University's Mitochondrial Research Group, his work centers on enhancing genomic diagnoses through new technologies and functional omics in NHS and academic settings.
Taylor's research specializations encompass the molecular characterisation of rare genomic conditions, particularly mitochondrial diseases and disorders of congenital autophagy, to improve patient access to reproductive options. His career has profoundly impacted mitochondrial genetics and pathology, with over 700 publications garnering more than 59,000 citations. Notable contributions include 'Use of Whole-Exome Sequencing to Determine the Genetic Basis of Multiple Mitochondrial Respiratory Chain Complex Deficiencies' (JAMA, 2014), which highlighted exome sequencing's role in identifying genetic causes of complex deficiencies; 'Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance' (Brain, 2014); and recent advances like 'Untargeted proteomics enables ultra-rapid variant prioritisation in mitochondrial and other rare diseases' (Genome Medicine, 2025), alongside studies on ACO2 variants and COA5's role in complex IV assembly. Through leadership in diagnostic services and high-impact research, Taylor has shaped clinical diagnostics and therapeutic strategies in mitochondrial medicine.